Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas
Doula
3 other identifiers
interventional
30
1 country
1
Brief Summary
The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 18, 2025
CompletedFirst Posted
Study publicly available on registry
September 5, 2025
CompletedResults Posted
Study results publicly available
February 19, 2026
CompletedFebruary 19, 2026
January 1, 2026
1.5 years
August 18, 2025
November 24, 2025
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Perceptions of Provider Communication
Assess patient's perception of their quality of communication with their provider using a Likert scale survey (ie. did the patient feel comfortable asking their prenatal provider questions regarding their health, did the patient feel listened to by their provider. Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediate postdelivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.
Study enrollment through 6-weeks postpartum
Perceptions of Maternal Care
Assess patient's perceptions of maternal care using a Likert scale survey (i.e. their physician spending time with the patient talking to them about their labor and delivery expectations) Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediately post-delivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.
Study enrollment through 6-weeks postpartum
Secondary Outcomes (12)
Perinatal Outcome - Gestational Age (GA) at Delivery
14-28 weeks GA through delivery
Perinatal Outcome - Number of Participants With Preterm <37 Weeks Births
14-28 weeks GA through delivery
Perinatal Outcome - Number of Participants With Cesarean Sections
14-28 weeks GA through delivery
Perinatal Outcome - Number of Participants With Gestational Hypertension/Preeclampsia
14-28 weeks GA through delivery
Neonatal Morbidity
Birth/delivery
- +7 more secondary outcomes
Study Arms (2)
Doula-Enhanced Care Group
EXPERIMENTALThis group received doula-enhanced care along with routine pregnancy care.
Routine Pregnancy Care Group
NO INTERVENTIONThis group received routine pregnancy care.
Interventions
Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.
Eligibility Criteria
You may qualify if:
- Black birthing people
- Received care and plan to delivery at the University of Kansas Medical Center
- Scored positive to social determinants of health screener
- Gestational age between 14-27.6 weeks at enrollment
You may not qualify if:
- Pregnancy not viable or pregnancy not intrauterine on ultrasound
- Patients who are not willing to be randomized into not receiving doula enhanced
- Patients who do not plan to delivery at the University of Kansas Health System
- Non-Black birthing people.
- Planned cesarean section
- Patients with a known major fetal anomaly
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Kansas Medical Centerlead
- BioNexus KCcollaborator
- Blue KC (Blue Cross Blue Shield)collaborator
Study Sites (1)
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Results Point of Contact
- Title
- Dr. Angela Martin, MD
- Organization
- The University of Kansas Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Martin, MD
University of Kansas Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2025
First Posted
September 5, 2025
Study Start
May 12, 2023
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
February 19, 2026
Results First Posted
February 19, 2026
Record last verified: 2026-01